Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Siderophore receptor and porin proteins are essential outer membrane components of Gram-negative bacteria that serve as the primary gateways for nutrient acquisition and molecular entry. Siderophore receptors, primarily TonB-dependent receptors (TBDRs), facilitate the active transport of iron-siderophore complexes across the outer membrane, a process powered by the TonB-ExbB-ExbD complex in the inner membrane (PMID: 22403408). Porins are protein channels that allow the passive diffusion of small, hydrophilic molecules, including many classes of antibiotics like beta-lactams and fluoroquinolones (PMID: 12654431). These proteins are exploited by "Trojan Horse" antibiotics, such as Cefiderocol, which mimics a siderophore to be actively transported into the periplasm, thereby bypassing common resistance mechanisms like porin loss or efflux pump upregulation (PMID: 30718271). Targeting these proteins is a critical strategy for treating multi-drug resistant (MDR) infections caused by pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae (PMID: 31533998). Resistance to drugs targeting these proteins often arises through the downregulation of porins or mutations in the siderophore transport machinery, presenting a significant therapeutic challenge.
Siderophore-mediated active transport (Trojan Horse mechanism) and passive diffusion through porin channels
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Siderophore receptor and porin proteins (TBDR/OMP).